Discover the vital role of the A1C test in diabetes management and how it can empower you to take control of your health. Learn about the significance of Hemoglobin A1C,
For Innovators & Clinicians: While GLP-1 agonists represent one of the most significant therapeutic breakthroughs in decades, their commercial and clinical potential is capped by a critical, unmet challenge: long-term
Orange Biomed exchanged key insights with industry experts while presenting our latest innovation at the 85th Scientific Sessions of the American Diabetes Association (ADA), held June 20-23, 2025, in Chicago.
Are you looking to navigate your own health and wellness journey? To support this goal, Orange Biomed sponsored a webinar featuring U.S. healthcare experts.
Hemoglobin A1C, Learn how it’s measured, its importance in diabetes management, factors affecting levels, & how to maintain healthy A1C for long-term health.
Join Orange Biomed at ADA Conference 2025 to explore OBM rapid A1c, a breakthrough in diabetes testing. Visit our booth for live demos and expert insights.
At CES 2025, we witnessed a wide array of AI-powered diagnostics and at-home health tech solutions. Discover how digital health innovators are addressing chronic diseases, overcoming commercialization challenges, and shaping
At the Consumer Electronics Show 2025, Orange Biomed showcased the OBM rapid A1c device, advancing healthcare with groundbreaking diabetes care innovation.
Discover the key differences, their roles in diabetes care, and how combining CGM and A1C methods can enhance diabetes management and improve health outcomes.
Stay informed about our launch and get exclusive updates straight to your inbox. Fill out the form below, and we’ll make sure you’re among the first to know when OBM rapid A1c test hits the market.
